These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
497 related items for PubMed ID: 22310631
1. Analysis of transplant outcomes after five or six human leukocyte antigen-mismatched living donor kidney transplantation. Lee HS, Kim MS, Kim YS, Joo DJ, Ju MK, Kim SJ, Kim SI, Huh KH, Park K. Transplant Proc; 2012 Jan; 44(1):273-5. PubMed ID: 22310631 [Abstract] [Full Text] [Related]
2. The effect of donor-recipient relationship on long-term outcomes of living related donor renal transplantation. Choi JY, Kwon OJ, Kang CM. Transplant Proc; 2012 Jan; 44(1):257-60. PubMed ID: 22310626 [Abstract] [Full Text] [Related]
3. Kidney transplantation in the US: an analysis of the OPTN/UNOS registry. Freitas MC. Clin Transpl; 2011 Jan; ():1-16. PubMed ID: 22755397 [Abstract] [Full Text] [Related]
4. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance. Waki K, Sugawara Y, Mizuta K, Fujita H, Kadowaki T, Kokudo N. Clin Transpl; 2011 Jan; ():223-35. PubMed ID: 22755416 [Abstract] [Full Text] [Related]
5. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL, Jin XB, Li XT, Wang HW, Lü JJ. Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748 [Abstract] [Full Text] [Related]
6. Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation. Thiyagarajan UM, Bagul A, Frost J, Horsburgh T, Nicholson ML. Transplant Proc; 2012 Jun 20; 44(5):1231-5. PubMed ID: 22663991 [Abstract] [Full Text] [Related]
7. Spousal versus living unrelated renal transplantation: a retrospective analysis of allograft outcomes. Solak I, Sezer TO, Toz H, Tatar E, Isayev C, Firat O, Hoscoskun C. Transplant Proc; 2012 Jun 20; 44(6):1710-2. PubMed ID: 22841250 [Abstract] [Full Text] [Related]
8. De novo donor specific antibodies and patient outcomes in renal transplantation. DeVos JM, Patel SJ, Burns KM, Dilioglou S, Gaber LW, Knight RJ, Gaber AO, Land GA. Clin Transpl; 2011 Jun 20; ():351-8. PubMed ID: 22755430 [Abstract] [Full Text] [Related]
9. The utilization and advantages of an exchange donor program in living donor renal transplantation: a single-center experience. Kim HS, Kwon OJ, Kang CM. Transplant Proc; 2012 Jan 20; 44(1):14-6. PubMed ID: 22310566 [Abstract] [Full Text] [Related]
10. Donor-specific HLA antibodies: risk factors and outcomes after kidney transplantation. Kanter Berga J, Pallardo Mateu LM, Beltran Catalan S, Puig Alcaraz N, Sancho Calabuig A, Gavela Martinez E, Avila Bernabeu A, Crespo Albiach J. Transplant Proc; 2011 Jan 20; 43(6):2154-6. PubMed ID: 21839219 [Abstract] [Full Text] [Related]
11. Clinical significance of post kidney transplant de novo DSA in otherwise stable grafts. Cooper JE, Gralla J, Chan L, Wiseman AC. Clin Transpl; 2011 Jan 20; ():359-64. PubMed ID: 22755431 [Abstract] [Full Text] [Related]
12. Effect of amino acid mismatch in the UNOS dataset. Sasaki N, El-Awar N, Idica A. Clin Transpl; 2011 Jan 20; ():299-309. PubMed ID: 22755423 [Abstract] [Full Text] [Related]
13. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients. Kuo HT, Huang E, Emami S, Pham PT, Wilkinson AH, Danovitch GM, Bunnapradist S. Transplantation; 2012 Mar 15; 93(5):493-502. PubMed ID: 22306574 [Abstract] [Full Text] [Related]
14. Using the mimetic epitope concept to find a possible way to widen the graft-survival difference between matched and mismatched renal transplants. Sasaki N, Idica A, Hall B, Terasaki PI. Clin Transpl; 2008 Mar 15; ():241-52. PubMed ID: 19711515 [Abstract] [Full Text] [Related]
15. The effect of recurrent glomerulonephritis and acute rejection episodes in zero human leukocyte antigen-mismatched kidney transplantation. Jeon HJ, Kim YS, Lee SM, Ahn C, Ha J, Kim SJ, Kim DK. Transplant Proc; 2012 Apr 15; 44(3):600-6. PubMed ID: 22483448 [Abstract] [Full Text] [Related]
16. Human leukocyte antigen and major histocompatibility complex class I-related chain A antibodies after kidney transplantation in Turkish renal transplant recipients. Seyhun Y, Ozdilli K, Oguz F, Karahan G, Onal E, Turkmen A, Eldegez U, Nane I, Çalişkan Y, Bakkaloglu H, Carin M. Transplant Proc; 2012 Apr 15; 44(6):1660-6. PubMed ID: 22841239 [Abstract] [Full Text] [Related]
17. The role of the altruistic unbalanced chain in exchange living donor renal transplantation: single-center experience. Ahn BK, Kwon OJ, Kang CM. Transplant Proc; 2012 Jan 15; 44(1):17-21. PubMed ID: 22310567 [Abstract] [Full Text] [Related]
18. Kidneys from older living donors provide excellent intermediate-term outcomes after transplantation. Balachandran VP, Aull MJ, Charlton M, Afaneh C, Serur D, Leeser DB, Del Pizzo J, Kapur S. Transplantation; 2012 Sep 15; 94(5):499-505. PubMed ID: 22892992 [Abstract] [Full Text] [Related]
19. Understanding the significance of low-level preformed donor-specific anti-HLA antibodies in renal transplant patients. Wu P, Everly MJ, Jin J, Mao Y, Chen J. Clin Transpl; 2011 Sep 15; ():365-8. PubMed ID: 22755432 [Abstract] [Full Text] [Related]
20. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience. Jin MK, Cho JH, Kwon O, Hong KD, Choi JY, Yoon SH, Park SH, Kim YL, Kim CD. Transplant Proc; 2012 Jan 15; 44(1):200-3. PubMed ID: 22310614 [Abstract] [Full Text] [Related] Page: [Next] [New Search]